A novel pharmaceutical preparation of Tripterygium wilfordii Hook. f. regulates macrophage polarization to alleviate inflammation in rheumatoid arthritis
A novel pharmaceutical preparation of Tripterygium wilfordii Hook. f. regulates macrophage polarization to alleviate inflammation in rheumatoid arthritis
复制标题
DOI:
10.1093/jpp/rgad078
复制
发表时间:
2023-09-20
影响因子:
3.3
通讯作者:
Li,Fangze
中科院分区:
文献类型:
--
作者:
Wan,Lei;Liu,Jian;Li,Fangze
ObjectivesTo validate the enhanced therapeutic effect ofTripterygium wilfordiiHook. f. (TWHF) in the treatment of rheumatoid arthritis (RA) by restoring homeostasis of M1/M2 macrophages.MethodsThis study, using random walk models and network pharmacology, examined the molecular targets and mechanism of TWHF in RA. Based on clinical observations and experiments in arthritis animal models, the effects of TWHF on macrophage polarization, related signal pathways, and targets were examined.Triptolide, a component of TWHF, was used to intervene arthritis rats.Key findingsNetwork pharmacological analysis revealed the key RA target genes related to TWHF. TWHF showed a strong correlation with the improvement of inflammatory indicators. TWHF inhibited the factors secreted by M1 macrophages such as IL-1β, IL-6, CXCL8, TNF-α, and VEGF-A, but promoted IL-10 from M2 macrophages. Quantitative liquid-phase chip assay showed thattriptolidereduced the levels of TNF-α, CXCL2, and VEGF, while IL-4 and IL-10 were increased in arthritis model. Meanwhile,triptolideinhibited the NF-κB, PI3K/AKT, and p38 MAPK signaling pathways, which in turn improved the RA joint inflammation and fixed immune imbalance.ConclusionsTriptolidedownregulate the expression of M1 macrophage-secreted factors that inhibit the overactivation of inflammatory signaling pathways.